Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Peter Choyke MD, FACR

Peter L. Choyke MD, FACR

Chief, Molecular Imaging Branch, National Cancer Institute; Senior Investigator, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland

Dr. Peter Choyke is a diagnostic radiologist at the National Cancer Institute with a long-standing focus on the imaging of genitourinary malignancies, particularly prostate cancer. He completed a residency at Yale and fellowship at Penn before joining the faculty at Georgetown University. In 1988, he moved to the NIH, where he is now the Chief of the Molecular Imaging Branch in the National Cancer Institute.


Dr. Choyke is an inventor, along with Brad Wood, MD and Peter Pinto, MD, on a US government patent for MRI-Ultrasound fusion biopsy of the prostate which was licensed to  Philips Medical Systems and became the product known as UroNav.